Birth Control Pills; Facts to Know

NWHRC Health Center - Birth Control Pills, March 16, 2005

* Birth control pills are extremely effective at preventing pregnancy. If used correctly and consistently (that is, no pills are missed and instructions are followed exactly), only one in 1,000 women is likely to get pregnant in the first year of use. With typical use, however, approximately 60 to 80 women in 1,000 are likely to get pregnant in the first year of use.

* The pill works mainly by preventing ovulation (about 90 to 95 percent of the time). It also works by thickening the mucus surrounding the cervix, which helps block sperm, reduces risk of PID, and thin the lining of the uterus so that if an egg was fertilized it would have trouble implanting.

* The pill is the most common form of reversible birth control used by women of childbearing age (ages 15 to 44). According to the National Center for Health Statistics, 10.4 million American women used the pill for pregnancy prevention in 1995. Over 18 million women in the U.S. are currently using BCPs according to a the Johns Hopkins School of Public Health.

* According to the National Cancer Institute, the most serious side effect of the pill continues to be an increased risk of cardiovascular disease in certain groups. Cardiovascular disease risks associated with pill use are highly dependent on your age. A recent analysis for the World Health Organization determined these facts:

* Among 1 million pill users under age 35, 20 percent of whom are smokers, fewer than 20 deaths per year could be attributed to pill use (less than 20 out of 1 million).

* Among 1 million pill users over age 35, 20 percent of whom are smokers, 24 to 96 deaths per year could be attributed to OC use (less than 100 out of 1 million).

*

Many women are unaware of the pill's protective effects. Birth control pills can improve menstrual problems like heavy bleeding, dysmenorrhea (pelvic cramps and pain), premenstrual syndrome and irregular cycles. They can prevent loss of bone density and reduce the risk of ovarian cysts. Pill use can also protect women from uterine and ovarian cancer.

* In 2002, results from the Women's Contraceptive and Reproductive Experience (Women's CARE) study indicated that present or past use among both Caucasian and African-American women ages 36 to 64 did not significantly increase the risk of breast cancer.

Curtis KM, Chrisman CE, Peterson HB. "Contraception for women in selected circumstances." Obstet Gynecol 2002;99:1100-1112.

"Emergency Contraception." Princeton University Office of Population Research. http://ec.princeton.edu. Date accessed: Sept. 2003.

"Estimates of the Risk of Cardiovascular Death Attributable to Low-Dose Oral Contraceptives in the United States." American Journal of Obstetrics and Gynecology, Vol. 180, pp. 241-249, Jan. 1999

"European evaluation concludes third generation pills are associated with a small increase in risk of venous thromboembolism" British Medical Journal. 323:828. October 13, 2001. http://bmj.bmjjournals.com. Accessed Sept. 2003.

"FDA Approves Seasonale Oral Contraceptive" FDA Talk Paper. Sept. 5, 2003. http://www.fda.gov. Accessed Sept. 2003.

Marchbanks, P.A, et al. "Oral Contraceptives and the Risk of Breast Cancer" NEJM 2002. Vol. 346:2025-2032, No. 26.

"Oral Contraceptives and Cancer Risk." National Cancer Institute. Reviewed Feb. 2003. Includes CARE and Collaborative Group on Hormonal Factors in Breast Cancer Study findings. http://cis.nci.nih.gov. Accessed Sept. 2003.

"Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of a BRCA1 or BRCA2 Mutation." New England Journal of Medicine 345(4): 235-240. July 26, 2001. http://content.nejm.org

Population Reports: Oral Contraceptives - An Update. Population Information Program, Center for Communication Programs. Information on health risks/benefits, CASH Study, The Johns Hopkins School of Public Health. Volume XXVIII, Number 1, Spring, 2000. http://www.jhuccp.org. Accessed Sept. 2003.

"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives." The Lancet 2001;358:1427-1429.

Schless, J.J. and Farley, T.M.M. Risk of cardiovascular disease in relation to oral contraception use with and without blood-pressure screening. Draft, Feb. 2000. Presented to meeting on Improving Access and Quality of Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use, World Health Organization, Geneva, Mar. 8-10, 2000. 27 p.

Schwartz, S.M., Petitti, D.B., Siscovick, D.S., Longstreth, W.T.J., Sidney, S., Raghunathan, T.E., Quesenberry, C.P.J., and Kelaghan, J. Stroke and use of low-dose oral contraceptives in young women: A pooled analysis of two US studies. Stroke 29(11): 2277-2284. Nov. 1998. http://stroke.ahajournals.org. Accessed Sept. 2003.

"Women in the Know." Ortho-McNeil Pharmaceutical, Inc. 2001. http://www.womenintheknow.com

Editorial Staff of the National Women's Health Resource Center 2002/01/03 2005/03/16 Now more than 40 years since it was first approved by the U.S. Food and Drug Administration in 1960, "the pill" continues to be the most popular and one of the most effective forms of reversible birth control ever invented. Amenorrhea,Birth control,Birth control pills,Contraception,Dysmenorrhea,Endometrium,Hormones,Mini-pill